Cite

HARVARD Citation

    Murtha, N. et al. (2023). Technical note: Investigating the suitability of existing facilities for a new Lu‐177 prostate‐specific membrane antigen therapy program. Medical physics. 50 (4), pp. 2380-2384. [Online]. 
  
Back to record